About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.
Subscribe to this blog's feed

Contact the Docs

Recent Posts

Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« USPTO News: Annual Fee Announced for Registered Practitioners | Main | Former House Ways and Means Economist Claims 7-Year Data Exclusivity Period Is Sufficient »

November 20, 2008

Pfizer and Stem Cell Sciences Sign Services Agreement

    By Jason Derry --

Stem Cell Sciences Stem Cell Sciences plc has announced an agreement with Pfizer Ltd., under which Stem Cell Sciences (SCS) will provide services that will support Pfizer's new regenerative medicine unit.  The partnership provides Pfizer with access to SCS's research services, cell lines, media, and reagents.  SCS provides its stem cell technology to biotechnology and pharmaceutical companies for drug discovery and research relating to regenerative therapeutics.  Pfizer Ltd. is the UK operating unit of Pfizer, Inc.  Pfizer's new Regenerative Medicine research unit launched Pfizer earlier this week (see Medical News Today report), and is co-located in Cambridge, UK and Cambridge, MA.  Pfizer's new unit is focused on stem cell biology research, and the discovery and development of new regenerative medicines.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.

Posted at 11:49 PM in Biotech/Pharma Business |

Comments

The comments to this entry are closed.

January 2025

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31  

Categories

Archives

More...